Page last updated: 2024-08-23

quinapril and Vascular Diseases

quinapril has been researched along with Vascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aschermann, M; Heller, S; Hlubocká, Z; Horký, K; Jáchymová, M; Jindra, A; Kvasnicka, J; Peleska, J; Umnerová, V1
Benetos, A; Lacolley, P; Safar, ME1

Trials

1 trial(s) available for quinapril and Vascular Diseases

ArticleYear
Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Journal of human hypertension, 2002, Volume: 16, Issue:8

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Endothelin-1; Endothelium, Vascular; Humans; Hypertension; Intercellular Adhesion Molecule-1; Isoquinolines; Male; Middle Aged; Predictive Value of Tests; Quinapril; Tetrahydroisoquinolines; Vascular Diseases; von Willebrand Factor

2002

Other Studies

1 other study(ies) available for quinapril and Vascular Diseases

ArticleYear
Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:6

    Topics: Animals; Aorta, Thoracic; Blood Pressure; Collagen; Fibrosis; Heart Rate; Hypertension; Isoquinolines; Mineralocorticoid Receptor Antagonists; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spironolactone; Tetrahydroisoquinolines; Vascular Diseases

1997